Break it Down: Quick access to quick ED fix from LTR Pharma

Stockheads

2024-12-12

Stockhead’s Break it Down brings you today’s leading market news in under 90 seconds.

In this episode, host Sarah Hughan tells all on LTR Pharma’s (ASX:LTP) online healthcare platform for Aussie men to access Spontan.

Spontan is a novel nasal spray designed to treat erectile dysfunction, and recent trials have shown a faster absorption than oral treatment.

Tune in to get the latest.

While LTR Pharma is a Stockhead advertiser, it did not sponsor this content.

Explore More

Investor Guide: Health & Biotech FY2025 featuring Tim Boreham

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2490713841"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2490713841\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2490713841?lang=zh_CN&edition=fundamental","thumbnail":"https://stockhead.com.au/wp-content/uploads/2024/12/LTP-1200x675-1-640x360.jpg","is_english":true,"pubTime":"2024-12-12 11:08","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2490713841","market":"us","top_or_hot":-1,"title":"Break it Down: Quick access to quick ED fix from LTR Pharma","media":"Stockheads","content":"<html><body><div><div></div></div><p>Stockhead’s Break it Down brings you today’s leading market news in under 90 seconds.</p><p>In this episode, host Sarah Hughan tells all on <strong>LTR Pharma’s (ASX:LTP)</strong> online healthcare platform for Aussie men to access Spontan.</p><p>Spontan is a novel nasal spray designed to treat erectile dysfunction, and recent trials have shown a faster absorption than oral treatment.</p><p>Tune in to get the latest.</p><p><i>While LTR Pharma is a Stockhead advertiser, it did not sponsor this content.</i></p><div></div><div> <h2>Explore More</h2> <ul><li> <img decoding=\"async\" height=\"169\" sizes=\"(max-width: 300px) 100vw, 300px\" src=\"https://stockhead.com.au/wp-content/uploads/2024/08/Health-and-Biotech-Investor-Guide-1200x675-1-300x169.jpg\" srcset=\"https://stockhead.com.au/wp-content/uploads/2024/08/Health-and-Biotech-Investor-Guide-1200x675-1-300x169.jpg 300w, https://stockhead.com.au/wp-content/uploads/2024/08/Health-and-Biotech-Investor-Guide-1200x675-1-1024x576.jpg 1024w, https://stockhead.com.au/wp-content/uploads/2024/08/Health-and-Biotech-Investor-Guide-1200x675-1-768x432.jpg 768w, https://stockhead.com.au/wp-content/uploads/2024/08/Health-and-Biotech-Investor-Guide-1200x675-1-640x360.jpg 640w, https://stockhead.com.au/wp-content/uploads/2024/08/Health-and-Biotech-Investor-Guide-1200x675-1.jpg 1200w\" width=\"300\"/> <span>Investor Guide: Health &amp; Biotech FY2025 featuring Tim Boreham</span> </li> </ul></div><div></div></body></html>","source":"stockheads_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Break it Down: Quick access to quick ED fix from LTR Pharma</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBreak it Down: Quick access to quick ED fix from LTR Pharma\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-12 11:08 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://stockhead.com.au/stockhead-tv/break-it-down/break-it-down-quick-access-to-quick-ed-fix-from-ltr-pharma/><strong>Stockheads</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Stockhead’s Break it Down brings you today’s leading market news in under 90 seconds.In this episode, host Sarah Hughan tells all on LTR Pharma’s (ASX:LTP) online healthcare platform for Aussie men to...</p>\n\n<a href=\"https://stockhead.com.au/stockhead-tv/break-it-down/break-it-down-quick-access-to-quick-ed-fix-from-ltr-pharma/\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4588","symbol_name":"碎股","start_time":0,"source_url":"https://stockhead.com.au/stockhead-tv/break-it-down/break-it-down-quick-access-to-quick-ed-fix-from-ltr-pharma/","article_id":"2490713841","we_media_id":null,"thumbnails":["https://stockhead.com.au/wp-content/uploads/2024/12/LTP-1200x675-1-640x360.jpg"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2490713841","pubTimestamp":1733972931,"columns":[],"sourceInfo":{"source_id":"stockheads_stock","name":"Stockheads"},"weMediaInfo":null,"summary":"Stockhead’s Break it Down brings you today’s leading market news in under 90 seconds.In this episode, host Sarah Hughan tells all on LTR Pharma’s  online healthcare platform for Aussie men to access Spontan.Spontan is a novel nasal spray designed to treat erectile dysfunction, and recent trials have shown a faster absorption than oral treatment.Tune in to get the latest.While LTR Pharma is a Stockhead advertiser, it did not sponsor this content. Explore More   Investor Guide: Health & Biotech FY2025 featuring Tim Boreham","collect":0,"end_time":0,"defaultTopTitle":"stockhead.com.au","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4588":"碎股","LU2346227817.USD":"BGF SUSTAINABLE GLOBAL INFRASTRUCTURE \"A2\" (USD) ACC","BK4208":"复合型公用事业","ED":"爱迪生联合电气","LU0170899867.USD":"EASTSPRING INVESTMENTS WORLD VALUE EQUITY  \"A\" (USD) ACC","BK4585":"ETF&股票定投概念"},"translate_title":"分解：快速获取LTR Pharma的quick ED fix","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ED":1},"content_text":"Stockhead’s Break it Down brings you today’s leading market news in under 90 seconds.In this episode, host Sarah Hughan tells all on LTR Pharma’s (ASX:LTP) online healthcare platform for Aussie men to access Spontan.Spontan is a novel nasal spray designed to treat erectile dysfunction, and recent trials have shown a faster absorption than oral treatment.Tune in to get the latest.While LTR Pharma is a Stockhead advertiser, it did not sponsor this content. Explore More   Investor Guide: Health & Biotech FY2025 featuring Tim Boreham","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"}}}